Sparking gains in Irish biotech firm Amarin (AMRN +8.6%) is a Leerink Swann note speculating that “patent progress could solidify Amarin as a prime takeout candidate given the blockbuster potential for [heart-drug candidate] AMR-101.” The firm had earlier said AMRN was moving toward winning its quest for U.S. patent protection for AMR-101.
Post your comment!
Penny Stock Picks
ThrowinShapes: completely agreed! $MINE
ThrowinShapes
powderbum: $CTTC. here comes the bounce:
powderbum
